abstract |
The present invention is directed to novel imidazolidin-2-one derivatives having a structure according to Formula I, wherein a, b, R, R, R, and R are as defined above, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor. |